SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-024181
Filing Date
2016-08-12
Accepted
2016-08-12 16:26:48
Documents
62
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q clsd-10q_20160630.htm 10-Q 1528849
2 EX-31.1 clsd-ex311_8.htm EX-31.1 15280
3 EX-31.2 clsd-ex312_6.htm EX-31.2 15275
4 EX-32.1 clsd-ex321_7.htm EX-32.1 9005
  Complete submission text file 0001564590-16-024181.txt   4747337

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT clsd-20160630.xml EX-101.INS 825201
6 XBRL TAXONOMY EXTENSION SCHEMA clsd-20160630.xsd EX-101.SCH 42248
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clsd-20160630_cal.xml EX-101.CAL 39691
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clsd-20160630_def.xml EX-101.DEF 132125
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE clsd-20160630_lab.xml EX-101.LAB 301172
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clsd-20160630_pre.xml EX-101.PRE 224191
Mailing Address 1220 OLD ALPHARETTA RD SUITE 300 ALPHARETTA GA 30005
Business Address 1220 OLD ALPHARETTA RD SUITE 300 ALPHARETTA GA 30005 678-270-4005
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37783 | Film No.: 161828550
SIC: 2834 Pharmaceutical Preparations